Asian markets trade higher as oil prices drop sharply. Multiple reports say crude prices fall by more than 4% after the United States and Iran pause attacks for a second consecutive night, easing immediate concerns about supply disruption. In equities, most Asian benchmarks are higher in early trading. Shares gain broadly even as investors monitor developments in the Middle East. A notable individual mover is Chinese chip designer CXMT, which rises strongly following its Shanghai debut, drawing attention from traders. The coverage links the relatively supportive risk sentiment in Asia to the lower oil price environment, with investors turning to stocks while the immediate escalation risk appears reduced. Overall, the story focuses on the combination of declining energy prices tied to a temporary de-escalation and steadier performance across regional markets, alongside the high-profile stock launch of CXMT in Shanghai.
Oil prices fall 4% as Asian stocks rise and CXMT debuts in Shanghai
Asian markets trade higher as oil prices drop sharply. Multiple reports say crude prices fall by more than 4% after the United States and Iran pause attacks for a second consecutive night, easing imme...
- Oil prices fall by more than 4% in reported trading.
- Asian stocks mostly rise during the session.
- The U.S. and Iran pause attacks for a second night, lowering escalation concerns.
- Chinese chipmaker CXMT jumps in Shanghai on its trading debut.
- CXMT’s debut is highlighted as a major market driver for investors.
Shares are mostly higher in Asia as oil prices slipped more than 4% after the U.S. and Iran paused their attacks for a second night
2 hours agoEricsson reports share buybacks for July 20–24, 2026
Telefonaktiebolaget LM Ericsson (publ) reports that it repurchases its own Class B shares during the period July 20 to J...
Sooryavanshi’s Zimbabwe knock reignites debate over Sanju Samson’s India T20I return
Vaibhav Sooryavanshi’s recent form in India’s T20I setup is renewing discussion around Sanju Samson’s return to the side...
AstraZeneca beats Q2 profit expectations and reiterates annual outlook
AstraZeneca reports stronger-than-expected second-quarter results and reiterates its annual guidance. In the three month...